open angle glaucoma (OAG) or ocular hypertension (OHT)
Conditions
Interventions
Group 1: 1 drop STN1012600 0.002% once daily
Group 2: 1 drop STN1012600 0.002% once daily
Group 3: 1 drop STN1012600 0.002% once daily and 1 drop Timolol 0.5% twice daily
Sponsors
Koji Oka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 18 years of age or older. Diagnosis of OAG or OHT in both eyes, or one eye with OAG and the other with OHT. Corrected Visual Acuity of +0.60 logMAR (Decimal visual acuity 0.3) or better in each eye.
Exclusion criteria
Exclusion criteria: Presence of any active severe external ocular disease, inflammation, or infection of the eye and/or eyelids in either eye. History of severe ocular trauma in either eye. Any condition that prevents clear visualization of the fundus in either eye. Known allergy, hypersensitivity or contraindications to any components of the study medications or other study related procedures/medications. History of ocular surgery specifically intended to lower IOP in either eye. History of keratorefractive surgery in either eye. Females who are pregnant, nursing, or planning a pregnancy. Subjects with known or suspected drug or alcohol abuse. Participation in other investigational drugs or device clinical trials within 30 days prior to Screening. Any decision by the Investigator to terminate a subject in screening or declare any subject ineligible for any sound medical reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Events Change and percent change from baseline in mean diurnal intraocular pressure at each post-baseline visit | — |
Contacts
Public ContactOka Koji
Santen pharmaceutical co.,ltd
Outcome results
None listed